Related Experiment Video
Updated: Jun 7, 2026

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
Published on: July 14, 2023
Elevated fibroblast growth factor 23 levels in a newborn with secondary hypoparathyroidism
Anneke Bech1, Karin Nabbe, Wim Brussel
1Department of Internal Medicine, Rijnstate Hospital, Wagnerlaan 55, 6800 TA Arnhem, The Netherlands.
Insights
Fibroblast growth factor 23 (FGF-23) is crucial for phosphate balance. This study reports extremely high FGF-23 levels in a newborn with transient hypoparathyroidism, which normalized over seven months.
Area of Science:
- Endocrinology
- Mineral Metabolism
- Pediatric Endocrinology
Background:
- Fibroblast growth factor 23 (FGF-23) is a key hormone regulating phosphate homeostasis.
- FGF-23 influences renal phosphate excretion and vitamin D synthesis.
- Limited data exists on FGF-23 levels in early infancy.
Purpose of the Study:
- To investigate FGF-23 levels in a newborn with transient secondary hypoparathyroidism.
- To understand the physiological significance of FGF-23 in newborns.
Main Methods:
- Case report of a newborn with transient secondary hypoparathyroidism due to maternal hyperparathyroidism.
- Measurement of FGF-23 levels at birth and during follow-up.
- Comparison of FGF-23 levels with maternal and healthy newborn ranges.
Main Results:
- Newborn presented with extremely high FGF-23 levels at birth (15,850 kRU/L), approximately 45 times higher than the mother's and 7 times higher than healthy newborns.
- FGF-23 levels gradually decreased, reaching the normal adult range by approximately 7 months of age.
- Transient secondary hypoparathyroidism was diagnosed in the infant.
Conclusions:
- This case highlights exceptionally high FGF-23 levels in a newborn with transient secondary hypoparathyroidism.
- The findings suggest a potential role for FGF-23 in neonatal mineral metabolism and its dynamic changes in early infancy.
- Further research is needed to elucidate the precise physiological functions of FGF-23 in newborns.
Abstract:
Fibroblast growth factor 23 (FGF-23) is a recently identified hormone that is of prime importance for phosphate homeostasis in humans. FGF-23 is secreted by osteocytes in response to phosphate-loading. It stimulates renal phosphate excretion and suppresses the formation of 1.25-dihydroxy-vitamin D by inhibiting renal 1α-hydroxylase activity. Knowledge about FGF-23 in early infancy is limited. We report here the case of a newborn with transient secondary hypoparathyroidism caused by maternal primary hyperparathyroidism during pregnancy. FGF-23 levels at birth were extremely high in the child (15.850 kilo-Relative Units per liter, kRU/L) (ie, ∼45 times higher than in the mother) and ∼7 times higher than in healthy newborns. The child's FGF-23 levels declined gradually and reached the normal adult range after ∼7 months. We discuss the potential physiologic significance of FGF-23 in newborns.
Related Concept Videos
The Parathyroid Glands
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hypothyroidism II: Pathophysiology
Roles of Electrolytes: Calcium and Phosphate
The calcium concentration in blood plasma is primarily regulated...
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Synthesis and Functions of Calcitonin
The exact mechanisms by which calcitonin operates in calcium homeostasis remain elusive, but its significance is evident in several vital...
Hyperthyroidism II: Pathophysiology
